Predictive role of quantification of myocardial fibrosis using delayed contrast-enhanced magnetic resonance imaging in nonischemic dilated cardiomyopathies: a systematic review and meta-analysis

Predictive role of quantification of myocardial fibrosis using delayed contrast-enhanced magnetic resonance imaging in nonischemic dilated cardiomyopathies: a systematic review and meta-analysis

Aim. The present study aims to provide a systematic review and meta-analysis to investigate the prognostic role of assessing the severity of myocardial fibrosis using delayed contrast-enhanced magnetic resonance imaging in nonischemic dilated cardiomyopathies.Material and methods. We searched PubMed...

Full description

Bibliographic Details
Main Authors:	E Z Golukhova, S A Aleksandrova, B Sh Berdibekov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2022-01-01
Series:	Российский кардиологический журнал
Subjects:	nonischemic dilated cardiomyopathy cardiac mri late gadolinium enhancement fibrosis severity predictive value prognosis
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/4776

Similar Items

Association Between Left Ventricular Mechanical Deformation and Myocardial Fibrosis in Nonischemic Cardiomyopathy
by: Ibolya Csecs, et al.
Published: (2020-10-01)

Role of cardiac MRI in nonischemic cardiomyopathies
by: Senthil Anand, et al.
Published: (2016-05-01)

Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy
by: Farah Cadour, et al.
Published: (2023-02-01)

Clinical Outcomes of Autologous Stem Cell–Patch Implantation for Patients With Heart Failure With Nonischemic Dilated Cardiomyopathy
by: Keitaro Domae, et al.
Published: (2021-07-01)

Restrictive annuloplasty or replacement on reverse remodeling for nonischemic dilated cardiomyopathy
by: Yusuke Misumi, et al.
Published: (2024-04-01)

Current status of the ICD in nonischemic cardiomyopathy
by: Venkatakrishnan Ramakumar, et al.
Published: (2018-01-01)

Tacrolimus-induced nonischemic dilated cardiomyopathy in a postrenal transplant recipient - A case report
by: Prawash Kumar Chowdhary, et al.
Published: (2022-01-01)

Beneficial Effect of Left Ventricular Remodeling after Early Change of Sacubitril/Valsartan in Patients with Nonischemic Dilated Cardiomyopathy
by: Hyue-Mee Kim, et al.
Published: (2021-04-01)

Left ventricular thrombus in patient with nonischemic cardiomyopathy: A case report
by: Trang Thi Thao Pham, MD, et al.
Published: (2024-11-01)

Diabetes mellitus is associated to high-risk late gadolinium enhancement and worse outcomes in patients with nonischemic dilated cardiomyopathy
by: Pablo Zulet, et al.
Published: (2024-01-01)

Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy
by: Kenji Okubo, et al.
Published: (2018-08-01)

Modification of ventriculo–arterial coupling by spironolactone in nonischemic dilated cardiomyopathy
by: Mark A. Lawson, et al.
Published: (2021-04-01)

Utilization of Cardiac Magnetic Resonance Imaging for Assessing Myocardial Fibrosis in Prognosis Evaluation and Risk Stratification of Patients with Dilated Cardiomyopathy
by: Xin-Yi Feng, et al.
Published: (2025-01-01)

Sudden cardiac deaths: Role of nonischemic myocardial disorders—Part 1
by: Pradeep Vaideeswar, et al.
Published: (2021-01-01)

Sudden cardiac deaths: Role of nonischemic myocardial disorders—Part II
by: Pradeep Vaideeswar, et al.
Published: (2021-01-01)

Left ventricular midwall fibrosis as a predictor of sudden cardiac death in non‐ischaemic dilated cardiomyopathy: a meta‐analysis
by: Jie Wang, et al.
Published: (2020-10-01)

Sudden cardiac death in patients with nonischemic cardiomyopathy
by: Brian P. Betensky, et al.
Published: (2014-01-01)

Diagnostic Role of Cardiovascular Magnetic Resonance Imaging in Dilated Cardiomyopathy
by: Nehal Singla, et al.
Published: (2021-01-01)

Is CRT-D superior to CRT-P in patients with nonischemic cardiomyopathy?
by: Mohammed Al-Sadawi, et al.
Published: (2023-02-01)

Cardiovascular Magnetic Resonance in Peripartum Cardiomyopathy: Comparison with Idiopathic Dilated Cardiomyopathy
by: Joanna Petryka-Mazurkiewicz, et al.
Published: (2021-09-01)

Cardiac magnetic resonance imaging in arrhythmogenic cardiomyopathy: evolving diagnostic criteria and new capabilities
by: S A. Aleksandrova, et al.
Published: (2024-12-01)

Etiology, clinical profile, and 1-year outcome of patients presenting with nonischemic ventricular tachycardia: An observational study
by: S V. V Mani Krishna, et al.
Published: (2022-01-01)

Cell therapy for nonischemic dilated cardiomyopathy: A systematic review and meta‐analysis of randomized controlled trials
by: Avnish Tripathi, et al.
Published: (2021-10-01)

Accelerated myocardial fibrosis in young to middle-aged patients with hypertrophic cardiomyopathy
by: Shiro Nakamori, et al.
Published: (2024-01-01)

Evaluation of idiopathic dilated cardiomyopathy with cardiac magnetic resonance imaging
by: Imtiyaz Ahmad Khan, et al.
Published: (2021-01-01)

Focal ischemic myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
by: Yang Zhi, et al.
Published: (2024-04-01)

Prognostic value of late gadolinium enhancement in cardiac MRI of non-ischemic dilated cardiomyopathy patients
by: Dibya Ranjan Behera, et al.
Published: (2020-09-01)

Cardiovascular Magnetic Resonance Imaging Findings in Africans with Idiopathic Dilated Cardiomyopathy
by: Nqoba Tsabedze, et al.
Published: (2023-02-01)

Prognostic value of myocardial strain and late gadolinium enhancement on cardiovascular magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy with moderate to severely reduced ejection fraction
by: Seung-Hoon Pi, et al.
Published: (2018-06-01)

Arrhythmic risk stratification in nonischemic dilated cardiomyopathy: The ReCONSIDER study design – A two-step, multifactorial, electrophysiology-inclusive approach
by: Konstantinos A. Gatzoulis, et al.
Published: (2021-03-01)

Signal-averaged electrocardiography as a noninvasive tool for evaluating the ventricular substrate in patients with nonischemic cardiomyopathy: reassessment of an old tool
by: Dinh Son Ngoc Nguyen, et al.
Published: (2024-04-01)

Identification of potential therapeutic targets for nonischemic cardiomyopathy in European ancestry: an integrated multiomics analysis
by: Kaijia Shi, et al.
Published: (2024-09-01)

An updated meta-analysis of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy
by: Fuwei Liu, et al.
Published: (2023-07-01)

Role of cardiovascular magnetic resonance in the evaluation of cardiomyopathy
by: Sulaiman Moosa, et al.
Published: (2016-11-01)

NOVEL METHODS OF PATIENTS SELECTION FOR THE CARDIAC RESYNCHRONIZING THERAPY IN NON-ISCHEMIC CARDIOMYOPATHY
by: D. I. Lebedev, et al.
Published: (2015-11-01)

Late gadolinium enhancement for re‐worsening left ventricular ejection fraction in patients with dilated cardiomyopathy
by: Takeru Nabeta, et al.
Published: (2021-02-01)

Arrhythmogenic Right Ventricular Cardiomyopathy: Characterization of Left Ventricular Phenotype and Differential Diagnosis With Dilated Cardiomyopathy
by: Alberto Cipriani, et al.
Published: (2020-03-01)

Electrocardiographic characteristics associated with late gadolinium enhancement and prognostic value in patients with dilated cardiomyopathy
by: Punyanuch Chayanopparat, et al.
Published: (2023-10-01)

Lack of Relationship between Fibrosis-Related Biomarkers and Cardiac Magnetic Resonance-Assessed Replacement and Interstitial Fibrosis in Dilated Cardiomyopathy
by: Paweł Rubiś, et al.
Published: (2021-05-01)

Association of uncertain significance genetic variants with myocardial mechanics and morphometrics in patients with nonischemic dilated cardiomyopathy
by: Karolina Mėlinytė-Ankudavičė, et al.
Published: (2024-04-01)